REPL
Replimune Group Inc
Price:  
8.50 
USD
Volume:  
2,189,932.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

REPL Relative Valuation

-1138.9%
Upside

As of 2025-11-07, the Relative Valuation of Replimune Group Inc (REPL) is (88.31) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.50 USD, the upside of Replimune Group Inc based on Relative Valuation is -1138.9%.

The range of the Relative Valuation is (84.36) - (92.26) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 23.5x - 25.7x 24.6x
Forward P/E multiples 23.5x - 25.7x 24.6x
Fair Price (84.36) - (92.26) (88.31)
Upside -1092.5% - -1185.4% -1138.9%
8.50 USD
Stock Price
(88.31) USD
Fair Price

REPL Relative Valuation - Historical P/E Data

Date P/E
2025-11-03 -2.59
2025-10-31 -2.71
2025-10-30 -2.86
2025-10-29 -2.84
2025-10-28 -2.91
2025-10-27 -2.60
2025-10-24 -2.45
2025-10-23 -2.35
2025-10-22 -2.31
2025-10-21 -2.26
2025-10-20 -2.49
2025-10-17 -1.25
2025-10-16 -1.30
2025-10-15 -1.32
2025-10-14 -1.21
2025-10-13 -1.27
2025-10-10 -1.26
2025-10-09 -1.29
2025-10-08 -1.27
2025-10-07 -1.30
2025-10-06 -1.30
2025-10-03 -1.32
2025-10-02 -1.30
2025-10-01 -1.17
2025-09-30 -1.17
2025-09-29 -1.21
2025-09-26 -1.15
2025-09-25 -1.13
2025-09-24 -1.16
2025-09-23 -1.21
2025-09-22 -0.91
2025-09-19 -0.90
2025-09-18 -0.96
2025-09-17 -1.59
2025-09-16 -1.61
2025-09-15 -1.58
2025-09-12 -1.60
2025-09-11 -1.67
2025-09-10 -1.67
2025-09-09 -1.62
2025-09-08 -1.68
2025-09-05 -1.76
2025-09-04 -1.62
2025-09-03 -1.64
2025-09-02 -1.64
2025-08-29 -1.50
2025-08-28 -1.50
2025-08-27 -1.54
2025-08-26 -1.58
2025-08-25 -1.53